Glenmark Among Top Pharma Picks: Prabhudas Lilladher

  • 13:26
  • Published On: October 28, 2015
Cinema View
Embed
Surjit Pal, pharma analyst at Prabhudas Lilladher, says Glenmark is expected to post better earnings for the September quarter compared to the previous quarter. The company's US revenues are likely to rise to $90-95 million from current average of $80-85 million going ahead, he adds.

Related Videos

India's Stock Markets Cheer Exit Polls
June 03, 2024 14:02
Massive Jump In Stock Market After Exit Polls Predict Big BJP Win
June 03, 2024 4:48
Markets & Elections: Buy, Hold Or Sell Ahead Of June 4
May 27, 2024 10:05
Nifty At All-Time High, Sensex Jumps Over 750 Points
May 23, 2024 2:18
Stock Market News: How Will Markets React To The Election Verdict
May 21, 2024 14:02
Taj Group Enters Luxury Residences Business. First Project In Chennai
May 16, 2024 6:57
Explained: Why Are Indian Markets On Edge During Lok Sabha Elections?
May 11, 2024 2:57
Markets Bleed: Sensex Tanks Over 1000 Points
May 09, 2024 2:25
Rakesh Jhunjhunwala's Wife Loses Rs 800 Crore As Her Biggest Stock Bet Tanks
May 08, 2024 1:06
Meet The Woman Who Built Her Six-Figure Food Business After Getting Laid Off
May 01, 2024 7:46
Kutch's Textile Craft Ajrakh Gets Geographical Indication Tag
April 28, 2024 2:31
What Does Launch Of Derivative Contracts On Nifty Next 50 Mean For You?
April 24, 2024 5:51
Our Offerings: NDTV
  • मध्य प्रदेश
  • राजस्थान
  • इंडिया
  • मराठी
  • 24X7
Choose Your Destination